Transaction in Own Shares

Summary by AI BETAClose X

Legal & General Group Plc has purchased 3,339,056 of its ordinary shares between August 10th and August 14th, 2026, as part of its share buyback program announced on March 11th, 2026. These repurchased shares will be cancelled, reducing the total number of ordinary shares in issue to 5,522,410,900, which also represents the total number of voting rights. The purchases were executed through its broker, Barclays Capital Securities Limited, with prices ranging from 296.60 to 312.40 pence per share.

Disclaimer*

Legal & General Group Plc
17 August 2026
 

LEGAL & GENERAL GROUP PLC
ISIN: GB0005603997
17th August 2026

 

LEI number: 213800JH9QQWHLO99821

 

Legal & General Group Plc (the "Company")
Transaction in Own Shares


The Company announces that from 10th August 2026 up to and including 14th August 2026 it had purchased a total of 3,339,056 of its ordinary shares of 2.5 pence each (the "ordinary shares"), through the Company's broker Barclays Capital Securities Limited as detailed below. The repurchased ordinary shares will be cancelled.

Date

Aggregate number of ordinary shares purchased

Highest price paid (per ordinary share)

Lowest price paid (per ordinary share)

Volume weighted average price

 

Trading venue

10th August 2026

 42,605

 312.20

 310.40

 311.23

XLON

10th August 2026

 102,856

 312.00

 309.60

 311.08

BATE

10th August 2026

 80,895

 312.10

 309.60

 311.07

TRQX

10th August 2026

 32,806

 312.10

 310.10

 311.23

AQXE

10th August 2026

 90,838

 312.40

 310.30

 311.11

CHIX

11th August 2026

 899,076

 306.10

 296.70

 299.84

XLON

11th August 2026

 358,996

 305.60

 296.70

 299.68

BATE

11th August 2026

 297,592

 305.50

 296.60

 299.07

TRQX

11th August 2026

 343,973

 304.20

 296.70

 299.80

AQXE

11th August 2026

 588,020

 306.10

 296.60

 299.36

CHIX

12th August 2026

 9,590

 303.50

 301.80

 302.39

XLON

12th August 2026

 57,757

 303.40

 300.40

 301.96

BATE

12th August 2026

 49,736

 303.50

 300.50

 302.02

TRQX

12th August 2026

 13,928

 302.80

 301.60

 302.18

AQXE

12th August 2026

 43,989

 303.70

 301.00

 302.21

CHIX

13th August 2026

 8,921

 300.60

 300.10

 300.22

XLON

13th August 2026

 59,549

 301.50

 298.30

 300.20

BATE

13th August 2026

 43,424

 301.70

 298.30

 300.46

TRQX

13th August 2026

 8,512

 301.00

 299.60

 300.29

AQXE

13th August 2026

 54,594

 301.80

 298.50

 300.51

CHIX

14th August 2026

 29,552

 303.90

 299.30

 302.01

XLON

14th August 2026

 40,648

 303.90

 299.40

 301.96

BATE

14th August 2026

 40,399

 303.80

 299.00

 301.88

TRQX

14th August 2026

 15,617

 303.60

 300.00

 302.13

AQXE

14th August 2026

 25,183

 303.70

 298.90

 301.56

CHIX

 

The purchases form part of the Company's share buyback programme announced on 11th March 2026.

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue shall be 5,522,410,900 ordinary shares.

No ordinary shares are held in treasury. Therefore, the total number of voting rights in the Company is 5,522,410,900.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as incorporated into and implemented under English law (including by virtue of the European Union (Withdrawal) Act 2018), the detailed breakdown of individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the share buyback programme is set out below.

http://www.rns-pdf.londonstockexchange.com/rns/9933Q_1-2026-8-17.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings